Cibc Private Wealth Group, LLC Global Blood Therapeutics, Inc. Transaction History

Cibc Private Wealth Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $3.82 Million - $5.11 Million	-117,741 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$38.94 - $50.85 $278,576 - $363,780	-7,154 Reduced 5.73%	117,741 $4.8 Million
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $2.01 Million - $3.4 Million	-53,369 Reduced 29.94%	124,895 $5.41 Million
Q3 2020 Nov 03, 2020	BUY	$52.76 - $74.49 $9.41 Million - $13.3 Million	178,264 New	178,264 $9.83 Million
Q3 2020 Oct 29, 2020	SELL	$52.76 - $74.49 $9.79 Million - $13.8 Million	-185,482 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $3.86 Million - $6.47 Million	79,127 Added 74.4%	185,482 $11.7 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $73,051 - $152,687	1,751 Added 1.67%	106,355 $5.43 Million
Q4 2019 Jan 30, 2020	BUY	$45.7 - $81.86 $4.78 Million - $8.56 Million	104,604 New	104,604 $8.31 Million
Q2 2018 Aug 02, 2018	SELL	$38.7 - $50.15 $270 - $351	-7 Closed	0 $0
Q1 2018 May 17, 2018	BUY	$39.6 - $65.9 $277 - $461	7 New	7 $0

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.